Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00013806
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2001-03-29
Brief Title:
CHP677 I-Metaiodobenzylguanidine I-MIBG Therapy for Refractory Neuroblastoma a Phase II Study
Sponsor:
National Center for Research Resources NCRR
Organization:
National Center for Research Resources NCRR
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2001-03-29
First Submit QC Date:
March 29 2001
Study First Post Date:
2001-03-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2005-06-23
Last Update Post Date:
2005-06-24
Last Update Post Date Type:
ESTIMATED